These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29511862)

  • 1. Adult normative values for the PATA Rate Test.
    Pane C; Costabile T; Salvati A; Aurisicchio DL; Abate F; Liguori A; Paciello F; Peluso S; Manganelli F; De Michele G; Filla A; Saccà F
    J Neurol; 2018 May; 265(5):1102-1105. PubMed ID: 29511862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Assessment of Dysarthria in Children with Cerebellar Syndrome Associated with PMM2-CDG.
    Itzep D; Martínez-Monseny AF; Bolasell M; Cuadras D; Velázquez-Fragua R; Gutierrez-Solana LG; Macaya A; Pérez-Dueñas B; Serrano M;
    Neuropediatrics; 2018 Dec; 49(6):408-413. PubMed ID: 30304743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests.
    Saccà F; Costabile T; Abate F; Liguori A; Paciello F; Pane C; De Rosa A; Manganelli F; De Michele G; Filla A
    J Neuropsychol; 2018 Sep; 12(3):471-483. PubMed ID: 28477351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for the Evaluation of Speech Intelligibility in Dysarthrias: Evidence of Reliability and Validity.
    dos Santos Barreto S; Zazo Ortiz K
    Folia Phoniatr Logop; 2015; 67(4):212-8. PubMed ID: 26771521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptual assessment of dysarthria: Comparison of a general and a detailed assessment protocol.
    Wannberg P; Schalling E; Hartelius L
    Logoped Phoniatr Vocol; 2016 Dec; 41(4):159-67. PubMed ID: 26443894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a method for assessment of dysarthria in a foreign language: a pilot study.
    Näsström AK; Schalling E
    Logoped Phoniatr Vocol; 2020 Apr; 45(1):39-48. PubMed ID: 31407612
    [No Abstract]   [Full Text] [Related]  

  • 7. Reliability, validity and normative data of a quick repetition test for Italian children.
    Tresoldi M; Ambrogi F; Favero E; Colombo A; Barillari MR; Velardi P; Schindler A
    Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):888-894. PubMed ID: 25912630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signs of dysarthria in adults with 22q11.2 deletion syndrome.
    Persson C; Laakso K; Edwardsson H; Lindblom J; Hartelius L
    Am J Med Genet A; 2017 Mar; 173(3):618-626. PubMed ID: 28127863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gauging the Auditory Dimensions of Dysarthric Impairment: Reliability and Construct Validity of the Bogenhausen Dysarthria Scales (BoDyS).
    Ziegler W; Staiger A; Schölderle T; Vogel M
    J Speech Lang Hear Res; 2017 Jun; 60(6):1516-1534. PubMed ID: 28538944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and Validity of Speech Evaluation in Adductor Spasmodic Dysphonia.
    Yanagida S; Nishizawa N; Hashimoto R; Mizoguchi K; Hatakeyama H; Homma A; Fukuda S
    J Voice; 2018 Sep; 32(5):585-591. PubMed ID: 28802787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perceptual analysis of dysarthria: presentation and validation of a clinical scale. Preliminary study].
    Ozsancak C; Parais AM; Auzou P
    Rev Neurol (Paris); 2002 Apr; 158(4):431-8. PubMed ID: 11984485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construct-related validity of the TOCS measures: comparison of intelligibility and speaking rate scores in children with and without speech disorders.
    Hodge MM; Gotzke CL
    J Commun Disord; 2014; 51():51-63. PubMed ID: 25069811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher-Faster-Farther: Maximum Performance Tests in the Assessment of Neurogenic Speech Impairment.
    Ziegler W; Schölderle T; Brendel B; Amsellem J; Staiger A
    Folia Phoniatr Logop; 2019; 71(5-6):261-274. PubMed ID: 31121591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis between apraxia and dysarthria based on acoustic analysis.
    Melle N; Gallego C
    Span J Psychol; 2012 Jul; 15(2):495-504. PubMed ID: 22774423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) Psychometric Characteristics: II European Portuguese Version (II EP CAPE-V).
    de Almeida SC; Mendes AP; Kempster GB
    J Voice; 2019 Jul; 33(4):582.e5-582.e13. PubMed ID: 29936062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Munich Intelligibility Profile. Studies of reliability and validity].
    Ziegler W; Hartmann E
    Nervenarzt; 1993 Oct; 64(10):653-8. PubMed ID: 8232679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frenchay dysarthria assessment (FDA-2) in Parkinson's disease: cross-cultural adaptation and psychometric properties of the European Portuguese version.
    Cardoso R; Guimarães I; Santos H; Loureiro R; Domingos J; de Abreu D; Gonçalves N; Pinto S; Ferreira J
    J Neurol; 2017 Jan; 264(1):21-31. PubMed ID: 27747392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.
    Defazio G; Guerrieri M; Liuzzi D; Gigante AF; di Nicola V
    Neurol Sci; 2016 Mar; 37(3):443-9. PubMed ID: 26615536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum performance tests in children with developmental spastic dysarthria.
    Wit J; Maassen B; Gabreëls FJ; Thoonen G
    J Speech Hear Res; 1993 Jun; 36(3):452-9. PubMed ID: 8331902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Intelligibility Gains in Individuals With Dysarthria From Baseline Speech Features.
    Fletcher AR; McAuliffe MJ; Lansford KL; Sinex DG; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3043-3057. PubMed ID: 29075753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.